Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (121-130 of 910) with videos related to

Pageof 91
Sort By:
Nature Reviews. Cardiology|July 8, 2016
Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathyBrandon W Calenda, Valentin Fuster, Jonathan L Halperin, et al.
European Heart Journal|February 7, 2013
Biomarkers in atrial fibrillation: a clinical reviewZiad Hijazi, Jonas Oldgren, Agneta Siegbahn, et al.
Circulation Research|June 7, 2014
Reperfusion strategies in acute coronary syndromesAkshay Bagai, George D Dangas, Gregg W Stone, et al.
American Heart Journal|November 14, 2017
Idarucizumab since FDA approval: Use in the real-worldJoseph Ebinger, Christopher B Granger, Alexander Zhu, et al.
American Heart Journal|December 9, 2003
Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategiesRichard E Waters, Kenneth W Mahaffey, Christopher B Granger, et al.
The Journal of the American Osteopathic Association|September 28, 2012
A new era of anticoagulation treatment: optimizing outcomes for atrial fibrillationCarman A Ciervo, Christopher B Granger, Frederick A Schaller, et al.
European Heart Journal|June 5, 2024
When cardiovascular medicines should be discontinuedKonstantin A Krychtiuk, Bernard J Gersh, Jeffrey B Washam, et al.
Trends in Pharmacological Sciences|July 8, 2015
Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injuryChristopher B Fordyce, Bernard J Gersh, Gregg W Stone, et al.
Expert Review of Cardiovascular Therapy|September 3, 2013
A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLEConnie N Hess, Sana M Al-Khatib, Christopher B Granger, et al.
JAMA Cardiology|August 4, 2020
Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic ReviewLeiah M Luoma, Cynthia M Westerhout, Christopher B Granger, et al.
Pageof 91

Showing results (121-130 of 910) with videos related to

Sort By:
Pageof 91
Nature Reviews. Cardiology|July 8, 2016
Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathyBrandon W Calenda, Valentin Fuster, Jonathan L Halperin, et al.
European Heart Journal|February 7, 2013
Biomarkers in atrial fibrillation: a clinical reviewZiad Hijazi, Jonas Oldgren, Agneta Siegbahn, et al.
Circulation Research|June 7, 2014
Reperfusion strategies in acute coronary syndromesAkshay Bagai, George D Dangas, Gregg W Stone, et al.
American Heart Journal|November 14, 2017
Idarucizumab since FDA approval: Use in the real-worldJoseph Ebinger, Christopher B Granger, Alexander Zhu, et al.
American Heart Journal|December 9, 2003
Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategiesRichard E Waters, Kenneth W Mahaffey, Christopher B Granger, et al.
The Journal of the American Osteopathic Association|September 28, 2012
A new era of anticoagulation treatment: optimizing outcomes for atrial fibrillationCarman A Ciervo, Christopher B Granger, Frederick A Schaller, et al.
European Heart Journal|June 5, 2024
When cardiovascular medicines should be discontinuedKonstantin A Krychtiuk, Bernard J Gersh, Jeffrey B Washam, et al.
Trends in Pharmacological Sciences|July 8, 2015
Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injuryChristopher B Fordyce, Bernard J Gersh, Gregg W Stone, et al.
Expert Review of Cardiovascular Therapy|September 3, 2013
A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLEConnie N Hess, Sana M Al-Khatib, Christopher B Granger, et al.
JAMA Cardiology|August 4, 2020
Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic ReviewLeiah M Luoma, Cynthia M Westerhout, Christopher B Granger, et al.
Pageof 91